Crinetics (CRNX) PT Raised to $97 at Citizens on Palsonify's EU Approval

April 28, 2026 4:06 AM

Citizens analyst Jonathan Wolleben raised the price target on Crinetics (NASDAQ: CRNX) to $97.00 (from $96.00) while maintaining a Market ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found